Navigation Links
The Leukemia & Lymphoma Society Announces Appointment of New President and CEO
Date:4/10/2008

John Walter, with LLS Since 1995, Tapped to Steer the World's Largest

Organization Dedicated to Blood Cancer Research and Patient Services

WHITE PLAINS, N.Y., April 10 /PRNewswire/ -- The Leukemia & Lymphoma Society has appointed John Walter as its president and chief executive officer, with the task of leading the world's largest organization dedicated to funding blood cancer research as it strives to find cures and prolong and enhance the lives of patients with leukemia, lymphoma and myeloma.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080410/NYTH074 )

Walter, who has been with LLS since 1995, most recently as chief operating officer, succeeds Dwayne Howell, Ph.D., who retired in February.

"After conducting a nationwide search, the LLS Board of Directors agreed that John Walter was the best candidate to steer us as we move toward achieving our mission of curing blood cancers and improving the lives of patients and their families," said LLS Chairman David Frantze. "The Leukemia & Lymphoma Society is a $300 million plus organization committed to identifying the best scientists in the world in the field of blood cancer research and providing the funding to help them find cures and better therapies. In John, we have somebody at the helm with the vision and leadership qualities to provide support for our patients in their journey dealing with these devastating diseases."

Walter started his career at LLS as senior vice president of finance and information technology, during which time he enhanced the efficiencies and internal controls of the organization by centralizing all finance and treasury operations in the United States and Canada. He also established LLS's information technology and Web functions.

He served as chief financial officer, and then, as executive vice president, strategic alliances and new business development he desi
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. The Leukemia & Lymphoma Society Hosts Workshop On Weighing Treatment Options For Chronic Myelogenous Leukemia
2. Study finds heart failure is rare among leukemia patients on imatinib
3. Altered expression of ultraconserved noncoding RNAs linked to human leukemias and carcinomas
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. Novel strategy under study for aggressive leukemia
7. Drug has ability to cure type of leukemia
8. The Leukemia & Lymphoma Society Provides Patients with the Latest Information on Myeloma
9. Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 (MEDI-538) in Patients with Acute Lymphoblastic Leukemia
10. Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies
11. St. Jude Finds Anti-Leukemia Drug Increases Patient Fatigue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Florida (PRWEB) November 21, 2014 TruDenta, ... chronic headaches and other jaw-related symptoms, has ... seeking relief from chronic head pain, neck pain, TMJ ... , “This year we have seen a 52% increase ... Our network of over 300 doctors and their teams ...
(Date:11/21/2014)... CDT PLUS! 2015 represents the ... everything needed to process dental insurance claims. View ... CDT 2015 codes are mandatory for reporting dental procedures ... 31, 2014. Dental professionals must use HIPAA mandated CDT ... There are significant changes in the CDT coding system ...
(Date:11/21/2014)... MO (PRWEB) November 21, 2014 ... Melancholy Lift, an industry leader in the ... people have significant feelings of sadness and depression ... from traditional pharmaceutical choices. Often, prescription drugs can ... depression. Prescription drugs are expensive and require regular ...
(Date:11/21/2014)... 21, 2014 According to a National ... June 11th, 2014, the inflating system found in certain ... airbag inflates. The force of inflation may cause the ... metal shards may pierce the airbag’s fabric and potentially ... , According to a Bloomberg Business Week article ...
(Date:11/21/2014)... London, UK (PRWEB) November 21, 2014 ... only ISO verified healthcare professional panel, today announced two important ... appointment of Roni DasGupta as President of Market Research, Americas ... Market Research, Europe. , Ms. DasGupta joined M3 ... President and most recently Head of Sales. Roni has ...
Breaking Medicine News(10 mins):Health News:National Rise In Patients Seeking Headache Relief 2Health News:PMIC Announces CDT PLUS! 2015, the Ultimate Coding Reference for Dentists and Oral Surgeons 2Health News:Depression Relief Product Receives Top 5-Star Rating from TopConsumerReviews.com 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 3Health News:M3 Global Research Announces Leadership Team Promotions in US and EU 2
... of unregulated tobacco products, the World Health Organisation (WHO) ... prevent more than five million deaths each year attributed ... anti-tobacco programmes, especially aimed at adolescent girls, among whom ... use, it finds, also continued to expand most rapidly ...
... public services watchdog, the hospitals in Scotland are failing to ... condition known as ‘Deep vein thrombosis’ (DVT), wherein a blood ... ,An enquiry that was conducted in the cases of ... the failure to diagnose the condition had resulted in the ...
... a doctor, today examined patients at the All India Institute ... end their strike or face termination of service. // ... terminate them from service,' he said when asked about the ... return to work., ,The minister, wearing the doctors' white ...
... The Supreme Court today has issued a notice to ... which a policy decision to implement 27 per cent ... quota issue continuing, the Supreme Court today decided to ... cent reservation to socially and economically backward classes in ...
... the students to end their agitation on the reservation issue. ... so contempt// action can be initiated against the students. ... left "patients at the mercy of God". ,"We ... If they are over-reaching our orders, they are in for ...
... President A P J Abdul Kalam today met representatives ... break the impasse with the students and doctors deciding// ... of agitating medicos, which also included members of AIIMS ... had a 45-minute meeting with Kalam. The medicos presented ...
Cached Medicine News:Health News:Hospitals In Scotland Not Diagnosing DVT Properly 2Health News:Supreme Court Verdict Gives Hope to Striking Medicos 2Health News:Supreme Court Warns Medicos of Contempt Action 2Health News:President Kalam Meets Striking Medicos However Stir to Continue 2
(Date:11/21/2014)... MONTREAL , 21. November 2014 ... hat heute bekannt gegeben, dass ... – EMA) die Kennzeichnung als Orphan-Medizinprodukt ... Produktkandidat des Unternehmens zur Behandlung von ... eine seltene, stark beeinträchtigende genetische Krankheit, ...
(Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... , Chief Executive Officer, will be presenting at the 26 ... York Palace Hotel in New York . ... at 2:00 PM ET. In addition, Mr. Krakauer and ... for separate one-on-one meetings during the day. ...
(Date:11/21/2014)... -- Depomed, Inc. (NASDAQ: DEPO ) today announced that ... Annual Healthcare Conference in New York City . ... for 8:00 am EST (5:00 am PST) on Tuesday December 2, ... accessed via the Investor Relations page of the Depomed website at ... for 30 days on the company,s website. About ...
Breaking Medicine Technology:Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2
... Inc. (Nasdaq: SGMO ) announced today that Edward ... the progress of Sangamo,s ZFP Therapeutic® development programs and an ... on Tuesday, March 8, 2011 at the Cowen and Company ... Boston. The presentation will be webcast live and ...
... Calif., March 1, 2011 DURECT Corporation (Nasdaq: ... Brown, President and Chief Executive Officer, will be presenting ... on Monday, March 7 at 1:00 pm Eastern Time. ... Place in Boston. (Logo:   http://photos.prnewswire.com/prnh/20020717/DRRXLOGO ...
Cached Medicine Technology:Sangamo BioSciences Announces Presentation at the Cowen and Company 31st Annual Health Care Conference 2DURECT to Present at Cowen and Company Health Care Conference 2
Titanium hemi arthroplasty implant for degenerative and post-traumatic arthritis of first metatarsophalangeal joint....
... Ad-Techs Cueva Cranial Nerve Electrodes ... skull base surgeries. Their patented circumferential ... nerve, and yields high-quality, stable real-time ... with valuable information during the removal ...
... As with all of Ad-Techs products, our Sphenoidal ... quality. They are available in stainless steel or ... or 2.75 inch (70 mm) long, 21 gauge ... electrodes are supplied as kits or sets. You ...
... is a medical device designed to handle ... capability, and archiving demands of the EEG ... framework that helps organize workflow and the ... centralized database and powerful search capability keeps ...
Medicine Products: